Inhibitor Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Inhibitor Therapeutics, Inc. (INTI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $0.04 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-03-26
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2024-03-31 was $0.07.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $0.04, a 42.86% decline from fiscal 2024.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $0.07.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $0.03, a 40.00% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.04 10-K · filed 2026-03-26 | |||
| 2025-09-30 | $0.04 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $0.04 10-Q · filed 2025-08-13 | |||
| 2024-12-31 | $0.07 10-K · filed 2026-03-26 | |||
| 2024-09-30 | $0.07 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $0.07 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | $0.07 10-Q · filed 2025-05-14 | |||
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 | |||
| 2020-12-31 | $0.03 10-K · filed 2022-03-30 | |||
| 2019-12-31 | $0.05 10-K · filed 2021-03-26 | |||
| 2018-12-31 | $0.24 10-K · filed 2020-03-30 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-03-07 |